Skip to main content
BLAU FARMACÊUTICA S.A. logo

BLAU FARMACÊUTICA S.A. — Investor Relations & Filings

ISIN · BRBLAUACNOR8 LEI · 254900YP8DZ5SO4GQR53 SA Manufacturing
Open in API
Filings indexed 101 across all filing types
Latest filing 2026-05-08 Regulatory Filings
Country BR Brazil
Listing SA

About BLAU FARMACÊUTICA S.A.

https://www.blau.com/

Blau Farmacêutica S.A. is a multinational corporation specializing in the institutional and hospital segments. As a pioneer in the development of biological products, the company develops and manufactures a diverse portfolio of high-complexity medications, including biologics, oncologicals, antibiotics, anesthetics, and antirheumatics. Its product range also encompasses specialized treatments for feminine health and uterine stimulation. The organization maintains a strong focus on research and development, utilizing proprietary manufacturing facilities to deliver advanced therapeutic solutions. With an international presence, the company provides high-quality medical products designed to meet the rigorous demands of healthcare institutions and specialized hospital environments.

Recent filings

Filing Released Lang Actions
ITR - Informações Trimestrais
Regulatory Filings
2026-05-08 Portuguese
-
Transaction in Own Shares Classification · 95% confidence The document is titled 'FORMULÁRIO INDIVIDUAL' and details securities trading activities by the company and its subsidiaries for the month 04/2026. It lists positions and movements in securities and derivatives, indicating no transactions occurred during the period. The content is a detailed report of securities holdings and transactions by the company itself and its controlled entities. This type of document corresponds to a report on transactions in own shares or securities held by the company and its affiliates. It is not an announcement, certification, or general regulatory filing. The document length is 4634 characters, which is sufficient to contain substantive data. Therefore, the document fits best under the category 'Transaction in Own Shares' (POS).
2026-05-06 Portuguese
-
Director's Dealing Classification · 95% confidence The document is titled 'FORMULÁRIO CONSOLIDADO' and details 'Negociação de Administradores e Pessoas Ligadas' which translates to 'Trading by Administrators and Related Persons'. It lists positions and movements (or lack thereof) of securities held by company insiders such as controllers, board members, and directors for the month 04/2026. There are no financial statements, earnings data, or management discussion. The document is a report on insider share transactions or holdings. This matches the definition of Director's Dealing (DIRS), which covers reports of personal share transactions by company directors and executives (insider trades). The document length is 3560 characters, which is consistent with a concise insider trading report. Therefore, the correct classification is DIRS with high confidence.
2026-05-06 Portuguese
Relatório Anual do Agente Fiduciário Exercício de 2025
Audit Report / Information Classification · 95% confidence The document is titled 'Relatório Anual do Agente Fiduciário' (Annual Report of the Fiduciary Agent) for the 6th Debenture Issuance by Blau Farmaceutica S.A. for the fiscal year 2025, with a base date of 31/12/2025. It contains detailed information about the debenture issuance characteristics, payments of interest and amortization, asset positions, financial indicators, compliance with CVM regulations (Brazilian Securities Commission), and a fiduciary agent declaration. The document is comprehensive, over 10,000 characters, and includes substantive financial data and analysis related to the debenture issuance and issuer's financial condition. It is not a simple announcement or certification but a full annual report by the fiduciary agent as required by CVM Resolution 17/2021 and Brazilian corporate law. Therefore, it fits best under the category of Audit Report / Information (AR), as it is a standalone report related to the audit and fiduciary oversight of the debenture issuance, not a full company annual report (10-K) or other categories like regulatory filings or announcements.
2026-04-29 Portuguese
-
Governance Information Classification · 95% confidence The document is the Estatuto Social (company bylaws) of Blau Farmacêutica S.A., detailing the company’s internal governance rules, corporate structure, objects of business, and subsidiary information. This is a governance charter rather than a financial report or an announcement. It falls squarely under Governance Information (CGR).
2026-04-22 Portuguese
Mapa Final de Votação Detalhado
Declaration of Voting Results & Voting Rights Announcements Classification · 97% confidence The document is titled “Assembleia Geral Ordinária e Extraordinária realizada em 22 de abril de 2026” and consists of detailed “Mapas Finais de Votação” (Final Voting Maps) showing vote counts for each agenda item at the shareholder meetings. It reports the official results of shareholder votes on approval of financial statements, allocation of earnings, remuneration of administrators, and bylaws amendments. This matches the definition for Declaration of Voting Results & Voting Rights Announcements (Code: DVA).
2026-04-22 Portuguese

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.